DrugCite
Search

NUTROPIN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Nutropin Adverse Events Reported to the FDA Over Time

How are Nutropin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Nutropin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Nutropin is flagged as the suspect drug causing the adverse event.

Most Common Nutropin Adverse Events Reported to the FDA

What are the most common Nutropin adverse events reported to the FDA?

Convulsion
81 (2.77%)
Headache
53 (1.81%)
Sudden Death
52 (1.78%)
Scoliosis
43 (1.47%)
Vomiting
33 (1.13%)
Pneumonia
31 (1.06%)
Fall
30 (1.03%)
Neoplasm Recurrence
28 (.96%)
Pyrexia
26 (.89%)
Respiratory Tract Infection
25 (.85%)
Arthralgia
24 (.82%)
Show More Show More
Intracranial Pressure Increased
24 (.82%)
Overdose
24 (.82%)
Craniopharyngioma
23 (.79%)
Condition Aggravated
21 (.72%)
Oedema Peripheral
21 (.72%)
Brain Neoplasm
19 (.65%)
Fatigue
19 (.65%)
Blood Glucose Increased
18 (.62%)
Death
18 (.62%)
Hypertension
18 (.62%)
Urticaria
18 (.62%)
Diabetes Mellitus
17 (.58%)
Gait Disturbance
17 (.58%)
Chest Pain
16 (.55%)
Diarrhoea
16 (.55%)
Lethargy
16 (.55%)
Renal Cancer
16 (.55%)
Hypoaesthesia
15 (.51%)
Abdominal Pain
14 (.48%)
Accidental Overdose
14 (.48%)
Benign Intracranial Hypertension
14 (.48%)
Dizziness
14 (.48%)
Hypoglycaemia
14 (.48%)
Medication Error
14 (.48%)
Respiratory Failure
14 (.48%)
Weight Decreased
14 (.48%)
Brain Oedema
13 (.44%)
Dehydration
13 (.44%)
Epiphysiolysis
13 (.44%)
Nausea
13 (.44%)
Pain In Extremity
13 (.44%)
Weight Increased
13 (.44%)
Pain
12 (.41%)
Cough
11 (.38%)
Device Failure
11 (.38%)
Joint Swelling
11 (.38%)
Meningioma
11 (.38%)
Papilloedema
11 (.38%)
Pituitary Tumour Benign
11 (.38%)
Visual Acuity Reduced
11 (.38%)
Asthenia
10 (.34%)
Bone Sarcoma
10 (.34%)
Cerebrovascular Accident
10 (.34%)
Cystic Fibrosis
10 (.34%)
Osteochondroma
10 (.34%)
Osteochondrosis
10 (.34%)
Somnolence
10 (.34%)
Drug Ineffective
9 (.31%)
Hypothyroidism
9 (.31%)
Injection Site Irritation
9 (.31%)
Medical Device Complication
9 (.31%)
Neoplasm Progression
9 (.31%)
Psoriasis
9 (.31%)
Recurrent Cancer
9 (.31%)
Viral Infection
9 (.31%)
Device Malfunction
8 (.27%)
Dyspnoea
8 (.27%)
Hepatic Cirrhosis
8 (.27%)
Hospitalisation
8 (.27%)
Hyperhidrosis
8 (.27%)
Incorrect Dose Administered
8 (.27%)
Injection Site Pain
8 (.27%)
Speech Disorder
8 (.27%)
Treatment Noncompliance
8 (.27%)
Aggression
7 (.24%)
Arrhythmia
7 (.24%)
Asthma
7 (.24%)
Back Pain
7 (.24%)
Blood Creatinine Increased
7 (.24%)
Breast Cancer
7 (.24%)
Colon Cancer Metastatic
7 (.24%)
Completed Suicide
7 (.24%)
Depression
7 (.24%)
Disturbance In Attention
7 (.24%)
Feeling Abnormal
7 (.24%)
Hyperglycaemia
7 (.24%)
Macular Oedema
7 (.24%)
Medulloblastoma
7 (.24%)
Migraine
7 (.24%)
Myocardial Infarction
7 (.24%)
Paraesthesia
7 (.24%)
Retinopathy
7 (.24%)
T-cell Lymphoma
7 (.24%)
Walking Disability
7 (.24%)
Acute Lymphocytic Leukaemia
6 (.21%)
Adrenal Insufficiency
6 (.21%)
Arteriovenous Malformation
6 (.21%)
Astrocytoma
6 (.21%)
Atelectasis
6 (.21%)
Clavicle Fracture
6 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Nutropin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nutropin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Nutropin

What are the most common Nutropin adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Nutropin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nutropin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Nutropin According to Those Reporting Adverse Events

Why are people taking Nutropin, according to those reporting adverse events to the FDA?

Growth Hormone Deficiency
534
Drug Use For Unknown Indication
134
Body Height Below Normal
106
Product Used For Unknown Indication
91
Hypopituitarism
84
Prader-willi Syndrome
74
Show More Show More
Growth Retardation
63
Renal Failure Chronic
48
Turners Syndrome
47
Unevaluable Event
14
Pituitary Tumour Benign
13
Hypothalamo-pituitary Disorder
11
Radiotherapy
10
Renal Failure
9
Empty Sella Syndrome
9
Craniopharyngioma
8
Failure To Thrive
8
Drug Therapy
7
Small For Dates Baby
6
Dwarfism
6
Noonan Syndrome
5
Blood Growth Hormone
5
Renal Disorder
5
Cystic Fibrosis
4
Neoplasm Malignant
4
Brain Neoplasm
4
Pituitary Tumour
4
Central Nervous System Neoplasm
4
Congenital Cystic Kidney Disease
3
Optic Nerve Hypoplasia
3
Acute Lymphocytic Leukaemia
3
Medulloblastoma
3
Lung Disorder
3
Chromosome Abnormality
3
Hepatic Cirrhosis
2
Surgery
2
Osteogenesis Imperfecta
2
Silver-russell Syndrome
2
Hypoglycaemia
2
Nervous System Disorder
2
Optic Tract Glioma
2
Hypothalamo-pituitary Disorders
2
Renal Dysplasia
2
Precocious Puberty
2
Osteoporosis
2
Blood Growth Hormone Decreased
2
Mucopolysaccharidosis Ih
2
Cardiovascular Disorder
2
Foetal Growth Retardation
2
Obesity
2
Thyroid Disorder
1

Drug Labels

LabelLabelerEffective
Nutropin Aq Nuspin 20Genentech, Inc.17-JAN-08
Nutropin Aq Pen 20Genentech, Inc.17-JAN-08
Nutropin AqGenentech, Inc.17-JAN-08
Nutropin Aq Pen 10Genentech, Inc.17-JAN-08
Nutropin Aq Nuspin 5Genentech, Inc.17-JAN-08
Nutropin Aq Nuspin 10Genentech, Inc.17-JAN-08
NutropinGenentech, Inc.06-MAR-12

Nutropin Case Reports

What Nutropin safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Nutropin. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Nutropin.